发明名称 Hexenone compounds and medical use thereof
摘要 The present invention relates to a compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate thereof; to a composition comprising a compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluent; and also to use of a compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate thereof for combating apoptosis, or preventing or treating a disease or disorder associated with apoptosis; and especially use for protecting cardiomyocyte, or preventing or treating a disease or disorder associated with cardiomyocyte apoptosis.;
申请公布号 US8884007(B2) 申请公布日期 2014.11.11
申请号 US201113696697 申请日期 2011.05.16
申请人 Institute of Pharmacology and Toxicology Medical Sciences P.L.A. China 发明人 Li Song;Zhong Wu;Liu Juan;Wang Lili;He Kunlun;Long Long;Xiao Junhai;Zheng Zhibing;Li Wei;Li Xin;Hu Guoliang
分类号 C07D295/215;C07D295/194 主分类号 C07D295/215
代理机构 Roberts Mlotkowski Safran & Cole, P.C. 代理人 Roberts Mlotkowski Safran & Cole, P.C.
主权项 1. A compound of Formula I, or pharmaceutically acceptable salt or solvate thereof, wherein: A represents ═S, —SR4 or ═O; X represents F, Cl, Br or I; R1 represents phenyl; R2, and R3 are attached together to form morpholine; and R4 represents C1-C6 alkyl.
地址 Beijing CN